<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38002002</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Long COVID in Older Adults.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3002</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11113002</ELocationID><Abstract><AbstractText>As time has passed following the COVID-19 pandemic, individuals infected with SARS-CoV-2 have gradually exhibited a variety of symptoms associated with long COVID in the postacute phase of infection. Simultaneously, in many countries worldwide, the process of population aging has been accelerating. Within this context, the elderly population has not only become susceptible and high-risk during the acute phase of COVID-19 but also has considerable risks when confronting long COVID. Elderly individuals possess specific immunological backgrounds, and during the process of aging, their immune systems can enter a state known as "immunosenescence". This further exacerbates "inflammaging" and the development of various comorbidities in elderly individuals, rendering them more susceptible to long COVID. Additionally, long COVID can inflict both physical and mental harm upon elderly people, thereby reducing their overall quality of life. Consequently, the impact of long COVID on elderly people should not be underestimated. This review seeks to summarize the infection characteristics and intrinsic factors of older adults during the COVID-19 pandemic, with a focus on the physical and mental impact of long COVID. Additionally, it aims to explore potential strategies to mitigate the risk of long COVID or other emerging infectious diseases among older adults in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yunguang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccines, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccines, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Huiwen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccines, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Longding</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1870-0035</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccines, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32070923</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2022SCP010</GrantID><Agency>The High-level Talent Promotion and Training Project of Kunming</Agency><Country/></Grant><Grant><GrantID>2021-I2M-1-043</GrantID><Agency>CAMS Innovation Fund for Medical Sciences</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">immunosenescence</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">public health</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38002002</ArticleId><ArticleId IdType="pmc">PMC10669899</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11113002</ArticleId><ArticleId IdType="pii">biomedicines11113002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 26 October 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Larsen J.R., Martin M.R., Martin J.D., Kuhn P., Hicks J.B. Modeling the Onset of Symptoms of COVID-19. Front. Public Health. 2020;8:473. doi: 10.3389/fpubh.2020.00473.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00473</ArticleId><ArticleId IdType="pmc">PMC7438535</ArticleId><ArticleId IdType="pubmed">32903584</ArticleId></ArticleIdList></Reference><Reference><Citation>LitCovid.  [(accessed on 31 May 2023)]; Available online:  https://www.ncbi.nlm.nih.gov/research/coronavirus/</Citation></Reference><Reference><Citation>Brugliera L., Spina A., Castellazzi P., Cimino P., Tettamanti A., Houdayer E., Arcuri P., Alemanno F., Mortini P., Iannaccone S. Rehabilitation of COVID-19 patients. J. Rehabil. Med. 2020;52:jrm00046. doi: 10.2340/16501977-2678.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2678</ArticleId><ArticleId IdType="pubmed">32286674</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. World Health Organization; Geneva, Swizerland: 2021.</Citation></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 31 May 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G., Diodati F., Puntoni M., Lazzarelli S., Marcomini B., Patrizi L., Caminiti C. Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:1541. doi: 10.3390/jcm11061541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Author Correction: Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:408. doi: 10.1038/s41579-023-00896-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00896-0</ArticleId><ArticleId IdType="pmc">PMC10408714</ArticleId><ArticleId IdType="pubmed">37069455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Klein S.L., Garibaldi B.T., Li H., Wu C., Osevala N.M., Li T., Margolick J.B., Pawelec G., Leng S.X. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res. Rev. 2021;65:101205. doi: 10.1016/j.arr.2020.101205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101205</ArticleId><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg E.M., Southerland L.T., Meltzer A.C., Pagenhardt J., Hoopes R., Camargo C.A., Jr., Kline J.A. Age-related differences in symptoms in older emergency department patients with COVID-19: Prevalence and outcomes in a multicenter cohort. J. Am. Geriatr. Soc. 2022;70:1918&#x2013;1930. doi: 10.1111/jgs.17816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17816</ArticleId><ArticleId IdType="pmc">PMC9115070</ArticleId><ArticleId IdType="pubmed">35460268</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934&#x2013;943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder G., Rezza G., Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323:1775&#x2013;1776. doi: 10.1001/jama.2020.4683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4683</ArticleId><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Salje H., Tran Kiem C., Lefrancq N., Courtejoie N., Bosetti P., Paireau J., Andronico A., Hoze N., Richet J., Dubost C.L., et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020;369:208&#x2013;211. doi: 10.1126/science.abc3517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc3517</ArticleId><ArticleId IdType="pmc">PMC7223792</ArticleId><ArticleId IdType="pubmed">32404476</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., the Northwell COVID-19 Research Consortium. Barnaby D.P., Becker L.B., Chelico J.D., et al. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052&#x2013;2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhach O., Meyer B., Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat. Rev. Microbiol. 2023;21:147&#x2013;161. doi: 10.1038/s41579-022-00822-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00822-w</ArticleId><ArticleId IdType="pmc">PMC9716513</ArticleId><ArticleId IdType="pubmed">36460930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhu B., Hong W., Zeng J., He X., Chen J., Zheng H., Qiu S., Deng Y., Chan J.C.N., et al. Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19. Int. J. Infect. Dis. 2020;98:252&#x2013;260. doi: 10.1016/j.ijid.2020.06.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.091</ArticleId><ArticleId IdType="pmc">PMC7326382</ArticleId><ArticleId IdType="pubmed">32619760</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K., Chen Y., Yuan J., Yi P., Ding C., Wu W., Li Y., Ni Q., Zou R., Li X., et al. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19) Clin. Infect. Dis. 2020;71:799&#x2013;806. doi: 10.1093/cid/ciaa351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa351</ArticleId><ArticleId IdType="pmc">PMC7184421</ArticleId><ArticleId IdType="pubmed">32271376</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T.Z., Cao Z.H., Chen Y., Cai M.T., Zhang L.Y., Xu H., Zhang J.Y., Ma C.H., Liu Y., Gao L.J., et al. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19. J. Med. Virol. 2021;93:506&#x2013;512. doi: 10.1002/jmv.26280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26280</ArticleId><ArticleId IdType="pmc">PMC7362127</ArticleId><ArticleId IdType="pubmed">32644223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.M., Hwang Y.J., Kwak Y. Prolonged SARS-CoV-2 detection and reversed RT-PCR results in mild or asymptomatic patients. Infect. Dis. 2021;53:31&#x2013;37. doi: 10.1080/23744235.2020.1820076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2020.1820076</ArticleId><ArticleId IdType="pubmed">32935628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu T., Wang Y., Zhou S., Zhang N., Xia L. A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19) J. Thorac. Imaging. 2020;35:W97&#x2013;W101. doi: 10.1097/RTI.0000000000000513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RTI.0000000000000513</ArticleId><ArticleId IdType="pmc">PMC7253040</ArticleId><ArticleId IdType="pubmed">32235187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Q., Ouyang X., Xie A., Tan X., Liu J., Huang F., Liu P. A retrospective study of the initial chest CT imaging findings in 50 COVID-19 patients stratified by gender and age. J. Xray Sci. Technol. 2020;28:875&#x2013;884. doi: 10.3233/XST-200709.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/XST-200709</ArticleId><ArticleId IdType="pmc">PMC7592672</ArticleId><ArticleId IdType="pubmed">32804112</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M., Liu Y., Xu D., Zhang R., Lan L., Xu H. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia. Korean J. Radiol. 2020;21:746&#x2013;755. doi: 10.3348/kjr.2020.0215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3348/kjr.2020.0215</ArticleId><ArticleId IdType="pmc">PMC7231610</ArticleId><ArticleId IdType="pubmed">32410413</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D., Guido G., Zerunian M., Polidori T., Lucertini E., Pucciarelli F., Polici M., Rucci C., Bracci B., Nicolai M., et al. Post-Acute Sequelae of COVID-19 Pneumonia: Six-month Chest CT Follow-up. Radiology. 2021;301:E396&#x2013;E405. doi: 10.1148/radiol.2021210834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210834</ArticleId><ArticleId IdType="pmc">PMC8335814</ArticleId><ArticleId IdType="pubmed">34313468</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021;27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.I., Yu K.M., Koh J.Y., Kim E.H., Kim S.M., Kim E.J., Casel M.A.B., Rollon R., Jang S.G., Song M.S., et al. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets. Nat. Commun. 2022;13:21. doi: 10.1038/s41467-021-27717-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27717-3</ArticleId><ArticleId IdType="pmc">PMC8748994</ArticleId><ArticleId IdType="pubmed">35013229</ArticleId></ArticleIdList></Reference><Reference><Citation>Speranza E., Purushotham J.N., Port J.R., Schwarz B., Flagg M., Williamson B.N., Feldmann F., Singh M., Perez-Perez L., Sturdevant G.L., et al. Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques. Life Sci. Alliance. 2022;5:e202101314. doi: 10.26508/lsa.202101314.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202101314</ArticleId><ArticleId IdType="pmc">PMC8807873</ArticleId><ArticleId IdType="pubmed">35039442</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair R.V., Vaccari M., Doyle-Meyers L.A., Roy C.J., Russell-Lodrigue K., Fahlberg M., Monjure C.J., Beddingfield B., Plante K.S., Plante J.A., et al. Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques. Am. J. Pathol. 2021;191:274&#x2013;282. doi: 10.1016/j.ajpath.2020.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2020.10.016</ArticleId><ArticleId IdType="pmc">PMC7648506</ArticleId><ArticleId IdType="pubmed">33171111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H.Y., He X.Y., Li W., Song T.Z., Han J.B., Yang X., Liu F.L., Luo R.H., Tian R.R., Feng X.L., et al. Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2. Signal. Transduct. Target. Ther. 2021;6:328. doi: 10.1038/s41392-021-00734-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00734-w</ArticleId><ArticleId IdType="pmc">PMC8409077</ArticleId><ArticleId IdType="pubmed">34471088</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P., Qi F., Xu Y., Li F., Liu P., Liu J., Bao L., Deng W., Gao H., Xiang Z., et al. Age-related rhesus macaque models of COVID-19. Anim. Model Exp. Med. 2020;3:93&#x2013;97. doi: 10.1002/ame2.12108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ame2.12108</ArticleId><ArticleId IdType="pmc">PMC7167234</ArticleId><ArticleId IdType="pubmed">32318665</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E., Sarapultsev A., Solomatina L., Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int. J. Mol. Sci. 2022;23:1716. doi: 10.3390/ijms23031716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A., Schurman S.H., Sen R., Ferrucci L. Human T cell immunosenescence and inflammation in aging. J. Leukoc. Biol. 2017;102:977&#x2013;988. doi: 10.1189/jlb.3RI0716-335R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3RI0716-335R</ArticleId><ArticleId IdType="pmc">PMC5597513</ArticleId><ArticleId IdType="pubmed">28733462</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawelec G. Hallmarks of human &#x201c;immunosenescence&#x201d;: Adaptation or dysregulation? Immun. Ageing. 2012;9:15. doi: 10.1186/1742-4933-9-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-9-15</ArticleId><ArticleId IdType="pmc">PMC3416738</ArticleId><ArticleId IdType="pubmed">22830639</ArticleId></ArticleIdList></Reference><Reference><Citation>Goronzy J.J., Weyand C.M. Understanding immunosenescence to improve responses to vaccines. Nat. Immunol. 2013;14:428&#x2013;436. doi: 10.1038/ni.2588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2588</ArticleId><ArticleId IdType="pmc">PMC4183346</ArticleId><ArticleId IdType="pubmed">23598398</ArticleId></ArticleIdList></Reference><Reference><Citation>Lothar Rink I.W. Encyclopedia of Infection and Immunity. Volume 1. Elsevier Inc.; Amsterdam, The Netherlands: 2022. Immunosenescence; pp. 259&#x2013;276.</Citation></Reference><Reference><Citation>De Martinis M., Franceschi C., Monti D., Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 2005;579:2035&#x2013;2039. doi: 10.1016/j.febslet.2005.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2005.02.055</ArticleId><ArticleId IdType="pubmed">15811314</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Monti D., Barbieri D., Grassilli E., Troiano L., Salvioli S., Negro P., Capri M., Guido M., Azzi R., et al. Immunosenescence in humans: Deterioration or remodelling? Int. Rev. Immunol. 1995;12:57&#x2013;74. doi: 10.3109/08830189509056702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830189509056702</ArticleId><ArticleId IdType="pubmed">7595015</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbe-Tuana F., Funchal G., Schmitz C.R.R., Maurmann R.M., Bauer M.E. The interplay between immunosenescence and age-related diseases. Semin. Immunopathol. 2020;42:545&#x2013;557. doi: 10.1007/s00281-020-00806-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-020-00806-z</ArticleId><ArticleId IdType="pmc">PMC7398288</ArticleId><ArticleId IdType="pubmed">32747977</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher S., Chahal H., Savey E., Killampalli V.V., Alpar E.K., Lord J.M. Functional Decline in Human Neutrophils with Age. Sci. World J. 2001;1:67. doi: 10.1100/TSW.2001.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1100/TSW.2001.105</ArticleId><ArticleId IdType="pmc">PMC6084520</ArticleId><ArticleId IdType="pubmed">30147538</ArticleId></ArticleIdList></Reference><Reference><Citation>Simell B., Vuorela A., Ekstrom N., Palmu A., Reunanen A., Meri S., Kayhty H., Vakevainen M. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine. 2011;29:1929&#x2013;1934. doi: 10.1016/j.vaccine.2010.12.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.12.121</ArticleId><ArticleId IdType="pubmed">21236231</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodig S., Cepelak I., Pavic I. Hallmarks of senescence and aging. Biochem. Med. 2019;29:030501. doi: 10.11613/BM.2019.030501.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2019.030501</ArticleId><ArticleId IdType="pmc">PMC6610675</ArticleId><ArticleId IdType="pubmed">31379458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hearps A.C., Martin G.E., Angelovich T.A., Cheng W.J., Maisa A., Landay A.L., Jaworowski A., Crowe S.M. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell. 2012;11:867&#x2013;875. doi: 10.1111/j.1474-9726.2012.00851.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2012.00851.x</ArticleId><ArticleId IdType="pubmed">22708967</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Garff-Tavernier M., Beziat V., Decocq J., Siguret V., Gandjbakhch F., Pautas E., Debre P., Merle-Beral H., Vieillard V. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell. 2010;9:527&#x2013;535. doi: 10.1111/j.1474-9726.2010.00584.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2010.00584.x</ArticleId><ArticleId IdType="pubmed">20477761</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayoso I., Sanchez-Correa B., Campos C., Alonso C., Pera A., Casado J.G., Morgado S., Tarazona R., Solana R. Immunosenescence of human natural killer cells. J. Innate Immun. 2011;3:337&#x2013;343. doi: 10.1159/000328005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000328005</ArticleId><ArticleId IdType="pubmed">21576928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazeldine J., Lord J.M. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res. Rev. 2013;12:1069&#x2013;1078. doi: 10.1016/j.arr.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2013.04.003</ArticleId><ArticleId IdType="pmc">PMC4147963</ArticleId><ArticleId IdType="pubmed">23660515</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegrist C.A., Aspinall R. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 2009;9:185&#x2013;194. doi: 10.1038/nri2508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2508</ArticleId><ArticleId IdType="pubmed">19240757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulati M., Buffa S., Candore G., Caruso C., Dunn-Walters D.K., Pellicano M., Wu Y.C., Colonna Romano G. B cells and immunosenescence: A focus on IgG+IgD-CD27- (DN) B cells in aged humans. Ageing Res. Rev. 2011;10:274&#x2013;284. doi: 10.1016/j.arr.2010.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2010.12.002</ArticleId><ArticleId IdType="pubmed">21185406</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D., Diaz A., Romero M., Garcia D., Blomberg B.B. B Cell Immunosenescence. Annu. Rev. Cell Dev. Biol. 2020;36:551&#x2013;574. doi: 10.1146/annurev-cellbio-011620-034148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-011620-034148</ArticleId><ArticleId IdType="pmc">PMC8060858</ArticleId><ArticleId IdType="pubmed">33021823</ArticleId></ArticleIdList></Reference><Reference><Citation>Goronzy J.J., Fang F., Cavanagh M.M., Qi Q., Weyand C.M. Naive T cell maintenance and function in human aging. J. Immunol. 2015;194:4073&#x2013;4080. doi: 10.4049/jimmunol.1500046.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500046</ArticleId><ArticleId IdType="pmc">PMC4452284</ArticleId><ArticleId IdType="pubmed">25888703</ArticleId></ArticleIdList></Reference><Reference><Citation>Stulnig T., Maczek C., Bock G., Majdic O., Wick G. Reference intervals for human peripheral blood lymphocyte subpopulations from &#x2019;healthy&#x2019; young and aged subjects. Int. Arch. Allergy Immunol. 1995;108:205&#x2013;210. doi: 10.1159/000237155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000237155</ArticleId><ArticleId IdType="pubmed">7580284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanni F., Vescovini R., Biasini C., Fagnoni F., Zanlari L., Telera A., Di Pede P., Passeri G., Pedrazzoni M., Passeri M., et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: A contribution to understand the relationship between inflammation and immunosenescence. Exp. Gerontol. 2003;38:981&#x2013;987. doi: 10.1016/S0531-5565(03)00160-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0531-5565(03)00160-8</ArticleId><ArticleId IdType="pubmed">12954485</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagger A., Shimojima Y., Goronzy J.J., Weyand C.M. Regulatory T cells and the immune aging process: A mini-review. Gerontology. 2014;60:130&#x2013;137. doi: 10.1159/000355303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000355303</ArticleId><ArticleId IdType="pmc">PMC4878402</ArticleId><ArticleId IdType="pubmed">24296590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroesen B.J., Teteloshvili N., Smigielska-Czepiel K., Brouwer E., Boots A.M., van den Berg A., Kluiver J. Immuno-miRs: Critical regulators of T-cell development, function and ageing. Immunology. 2015;144:1&#x2013;10. doi: 10.1111/imm.12367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12367</ArticleId><ArticleId IdType="pmc">PMC4264905</ArticleId><ArticleId IdType="pubmed">25093579</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C. Inflammaging as a major characteristic of old people: Can it be prevented or cured? Nutr. Rev. 2007;65:S173&#x2013;S176. doi: 10.1301/nr.2007.dec.S173-S176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1301/nr.2007.dec.S173-S176</ArticleId><ArticleId IdType="pubmed">18240544</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotas M.E., Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell. 2015;160:816&#x2013;827. doi: 10.1016/j.cell.2015.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.02.010</ArticleId><ArticleId IdType="pmc">PMC4369762</ArticleId><ArticleId IdType="pubmed">25723161</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullerton J.N., Gilroy D.W. Resolution of inflammation: A new therapeutic frontier. Nat. Rev. Drug Discov. 2016;15:551&#x2013;567. doi: 10.1038/nrd.2016.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2016.39</ArticleId><ArticleId IdType="pubmed">27020098</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D., Campisi J., Verdin E., Carrera-Bastos P., Targ S., Franceschi C., Ferrucci L., Gilroy D.W., Fasano A., Miller G.W., et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 2019;25:1822&#x2013;1832. doi: 10.1038/s41591-019-0675-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0675-0</ArticleId><ArticleId IdType="pmc">PMC7147972</ArticleId><ArticleId IdType="pubmed">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L., Fabbri E. Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty. Nat. Rev. Cardiol. 2018;15:505&#x2013;522. doi: 10.1038/s41569-018-0064-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0064-2</ArticleId><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 2014;69((Suppl. S1)):S4&#x2013;S9. doi: 10.1093/gerona/glu057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glu057</ArticleId><ArticleId IdType="pubmed">24833586</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil G.S. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177&#x2013;185. doi: 10.1038/nature21363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21363</ArticleId><ArticleId IdType="pubmed">28179656</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin C., Henao-Mejia J., Flavell R.A. Innate immune receptors: Key regulators of metabolic disease progression. Cell Metab. 2013;17:873&#x2013;882. doi: 10.1016/j.cmet.2013.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.05.011</ArticleId><ArticleId IdType="pubmed">23747246</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D., Chang J., Lartigue L., Bolen C.R., Haddad F., Gaudilliere B., Ganio E.A., Fragiadakis G.K., Spitzer M.H., Douchet I., et al. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. Nat. Med. 2017;23:174&#x2013;184. doi: 10.1038/nm.4267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4267</ArticleId><ArticleId IdType="pmc">PMC5320935</ArticleId><ArticleId IdType="pubmed">28092664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen P.R. Chronic Inflammatory Diseases and Atherosclerotic Cardiovascular Disease: Innocent Bystanders or Partners in Crime? Curr. Pharm. Des. 2018;24:281&#x2013;290. doi: 10.2174/1381612824666180110102341.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612824666180110102341</ArticleId><ArticleId IdType="pubmed">29318966</ArticleId></ArticleIdList></Reference><Reference><Citation>Gistera A., Hansson G.K. The immunology of atherosclerosis. Nat. Rev. Nephrol. 2017;13:368&#x2013;380. doi: 10.1038/nrneph.2017.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.51</ArticleId><ArticleId IdType="pubmed">28392564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta J., Mitra N., Kanetsky P.A., Devaney J., Wing M.R., Reilly M., Shah V.O., Balakrishnan V.S., Guzman N.J., Girndt M., et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin. J. Am. Soc. Nephrol. 2012;7:1938&#x2013;1946. doi: 10.2215/CJN.03500412.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.03500412</ArticleId><ArticleId IdType="pmc">PMC3513744</ArticleId><ArticleId IdType="pubmed">23024164</ArticleId></ArticleIdList></Reference><Reference><Citation>Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883&#x2013;899. doi: 10.1016/j.cell.2010.01.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.025</ArticleId><ArticleId IdType="pmc">PMC2866629</ArticleId><ArticleId IdType="pubmed">20303878</ArticleId></ArticleIdList></Reference><Reference><Citation>Todoric J., Antonucci L., Karin M. Targeting Inflammation in Cancer Prevention and Therapy. Cancer Prev. Res. 2016;9:895&#x2013;905. doi: 10.1158/1940-6207.CAPR-16-0209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.CAPR-16-0209</ArticleId><ArticleId IdType="pmc">PMC5142754</ArticleId><ArticleId IdType="pubmed">27913448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler O., Krogh J., Mors O., Benros M.E. Inflammation in Depression and the Potential for Anti-Inflammatory Treatment. Curr. Neuropharmacol. 2016;14:732&#x2013;742. doi: 10.2174/1570159X14666151208113700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X14666151208113700</ArticleId><ArticleId IdType="pmc">PMC5050394</ArticleId><ArticleId IdType="pubmed">27640518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers F., Milaneschi Y., de Jonge P., Giltay E.J., Penninx B. Metabolic and inflammatory markers: Associations with individual depressive symptoms. Psychol. Med. 2018;48:1102&#x2013;1110. doi: 10.1017/S0033291717002483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291717002483</ArticleId><ArticleId IdType="pubmed">28889804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz H., Alsrhani A., Zafar A., Javed H., Junaid K., Abdalla A.E., Abosalif K.O.A., Ahmed Z., Younas S. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health. 2020;13:1833&#x2013;1839. doi: 10.1016/j.jiph.2020.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.014</ArticleId><ArticleId IdType="pmc">PMC7402107</ArticleId><ArticleId IdType="pubmed">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Liang W.H., Zhao Y., Liang H.R., Chen Z.S., Li Y.M., Liu X.Q., Chen R.C., Tang C.L., Wang T., et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur. Respir. J. 2020;55 doi: 10.1183/13993003.00547-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00547-2020</ArticleId><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z., Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 2020;109:531&#x2013;538. doi: 10.1007/s00392-020-01626-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., Huang D., Ou P., Yu H., Zhu Z., Xia Z., Su Y., Ma Z., Zhang Y., Li Z., et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75:1742&#x2013;1752. doi: 10.1111/all.14309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14309</ArticleId><ArticleId IdType="pubmed">32239761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S., Xiang Y., Fang W., Zheng Y., Li B., Hu Y., Lang C., Huang D., Sun Q., Xiong Y., et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J. Med. Virol. 2020;92:797&#x2013;806. doi: 10.1002/jmv.25783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25783</ArticleId><ArticleId IdType="pmc">PMC7228368</ArticleId><ArticleId IdType="pubmed">32198776</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Guan W., Chen R., Wang W., Li J., Xu K., Li C., Ai Q., Lu W., Liang H., et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21:335&#x2013;337. doi: 10.1016/S1470-2045(20)30096-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30096-6</ArticleId><ArticleId IdType="pmc">PMC7159000</ArticleId><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Li X., Chen H., Yan S., Li D., Li Y., Gong Z. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am. J. Nephrol. 2020;51:343&#x2013;348. doi: 10.1159/000507471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000507471</ArticleId><ArticleId IdType="pmc">PMC7179524</ArticleId><ArticleId IdType="pubmed">32229732</ArticleId></ArticleIdList></Reference><Reference><Citation>Djaharuddin I., Munawwarah S., Nurulita A., Ilyas M., Tabri N.A., Lihawa N. Comorbidities and mortality in COVID-19 patients. Gac. Sanit. 2021;35((Suppl. S2)):S530&#x2013;S532. doi: 10.1016/j.gaceta.2021.10.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gaceta.2021.10.085</ArticleId><ArticleId IdType="pmc">PMC8677356</ArticleId><ArticleId IdType="pubmed">34929892</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S., Kim S.R., Kim M.N., Shim W.J., Park S.M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: A systematic review and meta-analysis. Heart. 2021;107:373&#x2013;380. doi: 10.1136/heartjnl-2020-317901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317901</ArticleId><ArticleId IdType="pubmed">33334865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Hsu C.K., Yen M.Y., Lee P.I., Ko W.C., Hsueh P.R. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 2023;56:1&#x2013;9. doi: 10.1016/j.jmii.2022.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType="pmc">PMC9576029</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Shen Y., Zhang X., Cen Y., Wang B., Zhao S., Zhou Y., Hu B., Wang M., et al. Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China. JAMA Netw. Open. 2021;4:e2127403. doi: 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Gursoy B., Surmeli C.D., Alkan M., Satici C., Altunok E.S., Kamat S., Demirok B., Demirkol M.A., Boru A. Cytokine storm in severe COVID-19 pneumonia. J. Med. Virol. 2021;93:5474&#x2013;5480. doi: 10.1002/jmv.27068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27068</ArticleId><ArticleId IdType="pmc">PMC8242613</ArticleId><ArticleId IdType="pubmed">33963559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. COVID-19: Immunopathology and its implications for therapy. Nat. Rev. Immunol. 2020;20:269&#x2013;270. doi: 10.1038/s41577-020-0308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0308-3</ArticleId><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Savin I.A., Zenkova M.A., Sen&#x2019;kova A.V. Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches. Int. J. Mol. Sci. 2022;23:14959. doi: 10.3390/ijms232314959.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314959</ArticleId><ArticleId IdType="pmc">PMC9735580</ArticleId><ArticleId IdType="pubmed">36499287</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald L.T. Healing after COVID-19: Are survivors at risk for pulmonary fibrosis? Am. J. Physiol. Lung Cell. Mol. Physiol. 2021;320:L257&#x2013;L265. doi: 10.1152/ajplung.00238.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00238.2020</ArticleId><ArticleId IdType="pmc">PMC7900916</ArticleId><ArticleId IdType="pubmed">33355522</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumla A., Hui D.S., Azhar E.I., Memish Z.A., Maeurer M. Reducing mortality from 2019-nCoV: Host-directed therapies should be an option. Lancet. 2020;395:e35&#x2013;e36. doi: 10.1016/S0140-6736(20)30305-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30305-6</ArticleId><ArticleId IdType="pmc">PMC7133595</ArticleId><ArticleId IdType="pubmed">32035018</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianello A., Guarnieri G., Braccioni F., Lococo S., Molena B., Cecchetto A., Giraudo C., Bertagna De Marchi L., Caminati M., Senna G. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Clin. Chem. Lab. Med. 2022;60:307&#x2013;316. doi: 10.1515/cclm-2021-1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1021</ArticleId><ArticleId IdType="pubmed">34783228</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., Neves P., Lima S.S., Lopes J.D.C., Torres M., Vallinoto I., Bichara C.D.A., Dos Santos E.F., de Brito M., da Silva A.L.S., et al. Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome. Front. Cell. Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams E.S., Martins T.B., Shah K.S., Hill H.R., Coiras M., Spivak A.M., Planelles V. Cytokine Deficiencies in Patients with Long-COVID. J. Clin. Cell. Immunol. 2022;13:672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894377</ArticleId><ArticleId IdType="pubmed">36742994</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves P., Quaresma J.A.S., Queiroz M.A.F., Silva C.C., Maia E.V., Oliveira J.S.S., Neves C., Mendonca S.D.S., Falcao A.S.C., Melo G.S., et al. Imbalance of Peripheral Temperature, Sympathovagal, and Cytokine Profile in Long COVID. Biology. 2023;12:749. doi: 10.3390/biology12050749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12050749</ArticleId><ArticleId IdType="pmc">PMC10215572</ArticleId><ArticleId IdType="pubmed">37237560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahearn-Ford S., Lunjani N., McSharry B., MacSharry J., Fanning L., Murphy G., Everard C., Barry A., McGreal A., Al Lawati S.M., et al. Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection. Allergy. 2021;76:2910&#x2013;2913. doi: 10.1111/all.14953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14953</ArticleId><ArticleId IdType="pmc">PMC8222932</ArticleId><ArticleId IdType="pubmed">34028045</ArticleId></ArticleIdList></Reference><Reference><Citation>Walle-Hansen M.M., Ranhoff A.H., Mellingsaeter M., Wang-Hansen M.S., Myrstad M. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021;21:199. doi: 10.1186/s12877-021-02140-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02140-x</ArticleId><ArticleId IdType="pmc">PMC7983098</ArticleId><ArticleId IdType="pubmed">33752614</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S., Zanjari N., Yassin M., Yassin Z., Tavahomi M. Association between long COVID, functional activity, and health-related quality of life in older adults. BMC Geriatr. 2023;23:40. doi: 10.1186/s12877-023-03757-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-023-03757-w</ArticleId><ArticleId IdType="pmc">PMC9868494</ArticleId><ArticleId IdType="pubmed">36690948</ArticleId></ArticleIdList></Reference><Reference><Citation>Engberg I., Segerstedt J., Waller G., Wennberg P., Eliasson M. Fatigue in the general population- associations to age, sex, socioeconomic status, physical activity, sitting time and self-rated health: The northern Sweden MONICA study 2014. BMC Public Health. 2017;17:654. doi: 10.1186/s12889-017-4623-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-017-4623-y</ArticleId><ArticleId IdType="pmc">PMC5557471</ArticleId><ArticleId IdType="pubmed">28806984</ArticleId></ArticleIdList></Reference><Reference><Citation>Avlund K. Fatigue in older adults: An early indicator of the aging process? Aging Clin. Exp. Res. 2010;22:100&#x2013;115. doi: 10.1007/BF03324782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03324782</ArticleId><ArticleId IdType="pubmed">20440097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V., Hall Dykgraaf S., Kidd M., Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3:e849&#x2013;e854. doi: 10.1016/S2666-7568(22)00245-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadore E.L., Izquierdo M. How to simultaneously optimize muscle strength, power, functional capacity, and cardiovascular gains in the elderly: An update. Age. 2013;35:2329&#x2013;2344. doi: 10.1007/s11357-012-9503-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-012-9503-x</ArticleId><ArticleId IdType="pmc">PMC3825007</ArticleId><ArticleId IdType="pubmed">23288690</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Chopra P. Chronic Fatigue Syndrome: From Chronic Fatigue to More Specific Syndromes. Eur. Neurol. 2018;80:73&#x2013;77. doi: 10.1159/000493531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493531</ArticleId><ArticleId IdType="pubmed">30286454</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancey J.R., Thomas S.M. Chronic fatigue syndrome: Diagnosis and treatment. Am. Fam. Physician. 2012;86:741&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">23062157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil V., Kwon H., Prado P., Hagelkruys A., Wimmer R.A., Stahl M., Leopoldi A., Garreta E., Hurtado Del Pozo C., Prosper F., et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181:905&#x2013;913 e907. doi: 10.1016/j.cell.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastenhuber E.R., Mercadante M., Nilsson-Payant B., Johnson J.L., Jaimes J.A., Muecksch F., Weisblum Y., Bram Y., Chandar V., Whittaker G.R., et al. Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry. eLife. 2022;11:e77444. doi: 10.7554/eLife.77444.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.77444</ArticleId><ArticleId IdType="pmc">PMC8942469</ArticleId><ArticleId IdType="pubmed">35294338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Calcaterra I., Molino A., Moretta P., Lupoli R., Spedicato G.A., Papa A., Motta A., Maniscalco M., Di Minno M.N.D. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines. 2021;9:957. doi: 10.3390/biomedicines9080957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080957</ArticleId><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Thachil J., Iba T., Levy J.H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7:e438&#x2013;e440. doi: 10.1016/S2352-3026(20)30145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Engelen M.M., Barco S., Spyropoulos A.C., Vanassche T., Hunt B.J., Vandenbriele C., Verhamme P., Kucher N., Rashidi F., et al. Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis. Thromb. Res. 2022;209:94&#x2013;98. doi: 10.1016/j.thromres.2021.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.11.029</ArticleId><ArticleId IdType="pmc">PMC8648604</ArticleId><ArticleId IdType="pubmed">34896917</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yu C., Jing H., Wu X., Novakovic V.A., Xie R., Shi J. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation. Front. Cell. Infect. Microbiol. 2022;12:861703. doi: 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Neugent M.L., Hulyalkar N.V., Nguyen V.H., Zimmern P.E., De Nisco N.J. Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection. mBio. 2020;11 doi: 10.1128/mBio.00218-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00218-20</ArticleId><ArticleId IdType="pmc">PMC7188990</ArticleId><ArticleId IdType="pubmed">32345639</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffatt M.F., Cookson W.O. The lung microbiome in health and disease. Clin. Med. 2017;17:525&#x2013;529. doi: 10.7861/clinmedicine.17-6-525.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.17-6-525</ArticleId><ArticleId IdType="pmc">PMC6297685</ArticleId><ArticleId IdType="pubmed">29196353</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpellini E., Ianiro G., Attili F., Bassanelli C., De Santis A., Gasbarrini A. The human gut microbiota and virome: Potential therapeutic implications. Dig. Liver. Dis. 2015;47:1007&#x2013;1012. doi: 10.1016/j.dld.2015.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2015.07.008</ArticleId><ArticleId IdType="pmc">PMC7185617</ArticleId><ArticleId IdType="pubmed">26257129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoneim H.E., Thomas P.G., McCullers J.A. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J. Immunol. 2013;191:1250&#x2013;1259. doi: 10.4049/jimmunol.1300014.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300014</ArticleId><ArticleId IdType="pmc">PMC4907362</ArticleId><ArticleId IdType="pubmed">23804714</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu L., Deng H., Ren Z., Zhao Y., Yu S., Guo Y., Dai J., Chen X., Li K., Li R., et al. Dynamic Changes in the Microbiome and Mucosal Immune Microenvironment of the Lower Respiratory Tract by Influenza Virus Infection. Front. Microbiol. 2019;10:2491. doi: 10.3389/fmicb.2019.02491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.02491</ArticleId><ArticleId IdType="pmc">PMC6838016</ArticleId><ArticleId IdType="pubmed">31736922</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z., Xiao Y., Kang L., Ma W., Shi L., Zhang L., Zhou Z., Yang J., Zhong J., Yang D., et al. Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019. Clin. Infect. Dis. 2020;71:713&#x2013;720. doi: 10.1093/cid/ciaa203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa203</ArticleId><ArticleId IdType="pmc">PMC7108196</ArticleId><ArticleId IdType="pubmed">32129843</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e948. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini F., Hertel J., Sandt E., Thinnes C.C., Neuberger-Castillo L., Pavelka L., Betsou F., Kruger R., Thiele I., Consortium N.-P. Parkinson&#x2019;s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol. 2020;18:62. doi: 10.1186/s12915-020-00775-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-020-00775-7</ArticleId><ArticleId IdType="pmc">PMC7285525</ArticleId><ArticleId IdType="pubmed">32517799</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A., Marshall T. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity. Front. Pediatr. 2018;6:373. doi: 10.3389/fped.2018.00373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00373</ArticleId><ArticleId IdType="pmc">PMC6288442</ArticleId><ArticleId IdType="pubmed">30564562</ArticleId></ArticleIdList></Reference><Reference><Citation>Carding S., Verbeke K., Vipond D.T., Corfe B.M., Owen L.J. Dysbiosis of the gut microbiota in disease. Microb. Ecol. Health Dis. 2015;26:26191. doi: 10.3402/mehd.v26.26191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/mehd.v26.26191</ArticleId><ArticleId IdType="pmc">PMC4315779</ArticleId><ArticleId IdType="pubmed">25651997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata H.J., Quagliarello V.J. The microbiota and microbiome in aging: Potential implications in health and age-related diseases. J. Am. Geriatr. Soc. 2015;63:776&#x2013;781. doi: 10.1111/jgs.13310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13310</ArticleId><ArticleId IdType="pmc">PMC4406803</ArticleId><ArticleId IdType="pubmed">25851728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X., Hu X., Ekumi I.O., Wang J., An Y., Li Z., Yuan B. Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups. Am. J. Geriatr. Psychiatry. 2020;28:1030&#x2013;1039. doi: 10.1016/j.jagp.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7347493</ArticleId><ArticleId IdType="pubmed">32753338</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D., Steptoe A., Bu F. Psychological consequences of long COVID: Comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long- and short-COVID groups. Br. J. Psychiatry. 2023;222:74&#x2013;81. doi: 10.1192/bjp.2022.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.155</ArticleId><ArticleId IdType="pmc">PMC7614126</ArticleId><ArticleId IdType="pubmed">36458509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadpour A., Sadeghmoghadam L., Shareinia H., Jahani S., Amiri F. Investigating the role of perception of aging and associated factors in death anxiety among the elderly. Clin. Interv. Aging. 2018;13:405&#x2013;410. doi: 10.2147/CIA.S150697.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S150697</ArticleId><ArticleId IdType="pmc">PMC5858545</ArticleId><ArticleId IdType="pubmed">29588578</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies R.E., Menzies R.G. Death anxiety in the time of COVID-19: Theoretical explanations and clinical implications. Cogn. Behav. Therap. 2020;13:e19. doi: 10.1017/S1754470X20000215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1754470X20000215</ArticleId><ArticleId IdType="pmc">PMC7308596</ArticleId><ArticleId IdType="pubmed">34191938</ArticleId></ArticleIdList></Reference><Reference><Citation>Khademi F., Moayedi S., Golitaleb M., Karbalaie N. The COVID-19 pandemic and death anxiety in the elderly. Int. J. Ment. Health Nurs. 2020;30:346&#x2013;349. doi: 10.1111/inm.12824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/inm.12824</ArticleId><ArticleId IdType="pmc">PMC7753683</ArticleId><ArticleId IdType="pubmed">33289213</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreescu C., Lee S. Anxiety Disorders in the Elderly. Adv. Exp. Med. Biol. 2020;1191:561&#x2013;576. doi: 10.1007/978-981-32-9705-0_28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-32-9705-0_28</ArticleId><ArticleId IdType="pubmed">32002946</ArticleId></ArticleIdList></Reference><Reference><Citation>Balsamo M., Cataldi F., Carlucci L., Fairfield B. Assessment of anxiety in older adults: A review of self-report measures. Clin. Interv. Aging. 2018;13:573&#x2013;593. doi: 10.2147/CIA.S114100.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S114100</ArticleId><ArticleId IdType="pmc">PMC5896683</ArticleId><ArticleId IdType="pubmed">29670342</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal U., Katikireddi S.V., McCowan C., Mulholland R.H., Azcoaga-Lorenzo A., Amele S., Fagbamigbe A.F., Vasileiou E., Grange Z., Shi T., et al. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2.57 million people in Scotland (EAVE II): A prospective cohort study. Lancet Respir. Med. 2021;9:1439&#x2013;1449. doi: 10.1016/S2213-2600(21)00380-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00380-5</ArticleId><ArticleId IdType="pmc">PMC8480963</ArticleId><ArticleId IdType="pubmed">34599903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahl A., Johnson S., Maine G., Garcia M.H., Nimmagadda S., Qu L., Chen N.W. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study. Lancet Reg. Health Am. 2021;4:100065. doi: 10.1016/j.lana.2021.100065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100065</ArticleId><ArticleId IdType="pmc">PMC8428472</ArticleId><ArticleId IdType="pubmed">34522911</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt A.A., Nafady-Hego H., Chemaitelly H., Abou-Samra A.B., Khal A.A., Coyle P.V., Kanaani Z.A., Kaleeckal A.H., Latif A.N., Masalmani Y.A., et al. Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination. Int. J. Infect. Dis. 2021;110:353&#x2013;358. doi: 10.1016/j.ijid.2021.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.08.008</ArticleId><ArticleId IdType="pmc">PMC8349447</ArticleId><ArticleId IdType="pubmed">34375762</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezas C., Coma E., Mora-Fernandez N., Li X., Martinez-Marcos M., Fina F., Fabregas M., Hermosilla E., Jover A., Contel J.C., et al. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with COVID-19 in nursing homes and healthcare workers in Catalonia: Prospective cohort study. BMJ. 2021;374:n1868. doi: 10.1136/bmj.n1868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1868</ArticleId><ArticleId IdType="pmc">PMC8371258</ArticleId><ArticleId IdType="pubmed">34407952</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo-Urdiales A., Spila Alegiani S., Fabiani M., Pezzotti P., Filia A., Massari M., Riccardo F., Tallon M., Proietti V., Del Manso M., et al. Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021. Euro Surveill. 2021;26 doi: 10.2807/1560-7917.ES.2021.26.25.2100507.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.25.2100507</ArticleId><ArticleId IdType="pmc">PMC8229378</ArticleId><ArticleId IdType="pubmed">34169819</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T., Hirose M., Inoue Y., Kunishima H., Otsubo T., Matsuda T. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. J. Med. Virol. 2022;94:3416&#x2013;3420. doi: 10.1002/jmv.27689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya H.I., Hagan T., Duraisingham S.S., Lee E.K., Kwissa M., Rouphael N., Frasca D., Gersten M., Mehta A.K., Gaujoux R., et al. Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures. Immunity. 2015;43:1186&#x2013;1198. doi: 10.1016/j.immuni.2015.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.11.012</ArticleId><ArticleId IdType="pmc">PMC4859820</ArticleId><ArticleId IdType="pubmed">26682988</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourati S., Cristescu R., Loboda A., Talla A., Filali A., Railkar R., Schaeffer A.K., Favre D., Gagnon D., Peretz Y., et al. Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination. Nat. Commun. 2016;7:10369. doi: 10.1038/ncomms10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10369</ArticleId><ArticleId IdType="pmc">PMC4729923</ArticleId><ArticleId IdType="pubmed">26742691</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukmanovic-Stejic M., Chambers E.S., Suarez-Farinas M., Sandhu D., Fuentes-Duculan J., Patel N., Agius E., Lacy K.E., Turner C.T., Larbi A., et al. Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammation. J. Allergy Clin. Immunol. 2018;142:844&#x2013;856. doi: 10.1016/j.jaci.2017.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.10.032</ArticleId><ArticleId IdType="pmc">PMC6127037</ArticleId><ArticleId IdType="pubmed">29155150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira B., Xu X.N., Akbar A.N. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly. Front. Immunol. 2020;11:583019. doi: 10.3389/fimmu.2020.583019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.583019</ArticleId><ArticleId IdType="pmc">PMC7592394</ArticleId><ArticleId IdType="pubmed">33178213</ArticleId></ArticleIdList></Reference><Reference><Citation>Crooke S.N., Ovsyannikova I.G., Poland G.A., Kennedy R.B. Immunosenescence and human vaccine immune responses. Immun. Ageing. 2019;16:25. doi: 10.1186/s12979-019-0164-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-019-0164-9</ArticleId><ArticleId IdType="pmc">PMC6743147</ArticleId><ArticleId IdType="pubmed">31528180</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T., Larbi A., Pawelec G., Cohen A.A., Provost G., Khalil A., Lacombe G., Rodrigues S., Desroches M., Hirokawa K., et al. Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change. Vaccines. 2022;10:607. doi: 10.3390/vaccines10040607.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10040607</ArticleId><ArticleId IdType="pmc">PMC9030923</ArticleId><ArticleId IdType="pubmed">35455356</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Salvioli S., Garagnani P., de Eguileor M., Monti D., Capri M. Immunobiography and the Heterogeneity of Immune Responses in the Elderly: A Focus on Inflammaging and Trained Immunity. Front. Immunol. 2017;8:982. doi: 10.3389/fimmu.2017.00982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00982</ArticleId><ArticleId IdType="pmc">PMC5559470</ArticleId><ArticleId IdType="pubmed">28861086</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>